The global market for BioPharma Contract Development & Manufacturing (CDMO) is forecast to keep expanding. The European CDMO market is projected to grow at a CAGR of 5% to 7.4% according to various reports.
This infographic summarises the main players with facilities in Europe who develop and manufacture Small Molecule, Biologics and Cell & Gene therapy drug products.
Download your high resolution infographic by filling out the short form.
Note: Due to the high number of Small Molecule manufacturers in Europe, we have only included CDMOs with in this category with more than one facility.
While every effort has been made to capture all contract manufacturers in the infographic, we are not yet comprehensive.
In addition, this map of 527 CDMO manufacturing sites across Europe reveals the countries with the most facilities in operation.
Created in partnership with Fuliginous Management Consulting the infographic highlights the countries which have the most facilities in Europe who develop and manufacture Finished Dosage Forms (FDF) of small molecules.
CDMO Live is the ultimate online partnering event for bio/pharma outsourcing.
Join this exclusive event on 7-8 May 2025 to discover the latest trends and best practices in contract manufacturing, and connect with leading partners who can accelerate and de-risk your small molecule and biologic projects. Find out more
Download the high resolution infographic
Stay ahead of trends and best practices 
Exclusive downloads and podcasts 
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
